FHIR IG Statistics: ValueSet/valueset-genericFacilityMessageTypes
| Package | hl7.fhir.us.spl |
| Type | ValueSet |
| Id | valueset-genericFacilityMessageTypes |
| FHIR Version | R5 |
| Source | http://hl7.org/fhir/us/spl/https://build.fhir.org/ig/HL7/fhir-spl/ValueSet-valueset-genericFacilityMessageTypes.html |
| URL | http://hl7.org/fhir/us/spl/ValueSet/valueset-genericFacilityMessageTypes |
| Version | 0.2.8 |
| Status | active |
| Date | 2025-07-07T15:17:39+00:00 |
| Name | GenericFacilityMessageTypes |
| Title | Generic Facility Message Types |
| Realm | us |
| Authority | hl7 |
| Description | The set of message types that are allowed as a Generic User Fee Facility submission. |
| Copyright | This material contains content from LOINC (http://loinc.org). LOINC is copyright © 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license. LOINC® is a registered United States trademark of Regenstrief Institute, Inc |
Resources that use this resource
Resources that this resource uses
| CodeSystem |
| loinc.org | LOINC Code System |
| loinc.org | LOINC codes used in this IG |
| loinc.org | Logical Observation Identifiers, Names and Codes (LOINC) |
Narrative
Note: links and images are rebased to the (stated) source
- Include these codes as defined in
http://loinc.org| Code | Display |
| 71743-9 | GENERIC DRUG FACILITY IDENTIFICATION SUBMISSION |
| 72090-4 | IDENTIFICATION OF CBER-REGULATED GENERIC DRUG FACILITY |
Source
{
"resourceType": "ValueSet",
"id": "valueset-genericFacilityMessageTypes",
"text": {
"status": "generated",
"div": "<!-- snip (see above) -->"
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-wg",
"valueCode": "brr"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
"valueInteger": 1,
"_valueInteger": {
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
"valueCanonical": "http://hl7.org/fhir/us/spl/ImplementationGuide/hl7.fhir.us.spl"
}
]
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
"valueCode": "trial-use",
"_valueCode": {
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
"valueCanonical": "http://hl7.org/fhir/us/spl/ImplementationGuide/hl7.fhir.us.spl"
}
]
}
}
],
"url": "http://hl7.org/fhir/us/spl/ValueSet/valueset-genericFacilityMessageTypes",
"version": "0.2.8",
"name": "GenericFacilityMessageTypes",
"title": "Generic Facility Message Types",
"status": "active",
"experimental": false,
"date": "2025-07-07T15:17:39+00:00",
"publisher": "HL7 International / Biomedical Research and Regulation",
"contact": [
{
"name": "HL7 International / Biomedical Research and Regulation",
"telecom": [
{
"system": "url",
"value": "http://www.hl7.org/Special/committees/rcrim"
}
]
}
],
"description": "The set of message types that are allowed as a Generic User Fee Facility submission.",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US",
"display": "United States of America"
}
]
}
],
"copyright": "This material contains content from LOINC (http://loinc.org). LOINC is copyright © 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license. LOINC® is a registered United States trademark of Regenstrief Institute, Inc",
"compose": {
"include": [
{
"system": "http://loinc.org",
"concept": [
{
"code": "71743-9",
"display": "GENERIC DRUG FACILITY IDENTIFICATION SUBMISSION"
},
{
"code": "72090-4",
"display": "IDENTIFICATION OF CBER-REGULATED GENERIC DRUG FACILITY"
}
]
}
]
}
}
FHIR